PhD Uroš Urleb
no.: 01878

researcher – active in research organisation

Research activity

Code	Science	Field	Subfield
1.09.00	Natural sciences and mathematics	Pharmacy

Keywords

Medicinal chemistry, drug design, peptidomimetics, drug analysis, nir spectroscopy

Bibliography Representative bibliographic units | Personal | COBISS+

Evaluation (metodology)

Points

A''

A1/2

CI10

642

CImax

101

h10

Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024

Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )

Database	Linked records	Citations	Pure citations	Average pure citations
WoS	102	1,453	1,147	11.25
Scopus	107	1,690	1,369	12.79

Mentoring junior researchers

no.	Name and surname	Type	Period	Code
1	PhD Tomaž Bratkovič	Uniform doctoral studies	1/1/2003 - 8/31/2005	23598
2	PhD Aleš Obreza	Doctoral degree	11/1/1998 - 5/31/2002	19061
3	KATARINA VERHNJAK	Master's degree	6/1/1992 - 5/31/1995	12633
4	VESNA LESKOVŠEK	Master's degree	4/1/1992 - 3/31/1995	12632

Doctoral dissertations and other final papers Show

Employments

Type of employment	Research org.	Research group
Full time employment (20%, RD:0%)	University of Ljubljana, Faculty of Pharmacy	Chair for Pharmaceutical Chemistry
Full time employment (100%, RD:100%)	Novartis Pharmaceutical Manufacturing LLC	Raziskovalna skupina Novartis d.o.o. (Slovene)

Research projects Legend

no.	Code	Title	Period	Head	No. of publications
1.	L2-1112	Tehnologije znanj za odkrivanje novih zdravilnih učinkovin: analiza in načrtovnje eksperimentov v visokozmogljivostni genetiki (Slovene)	2/1/2008 - 1/31/2011	PhD Blaž Zupan	3,216
2.	L1-9596	Molecular mechanism of novel hypolipidemics	7/1/2007 - 12/31/2008	PhD Uroš Urleb	1,878
3.	J1-7584	Novel Mur ligase inhibitors	9/1/2005 - 8/31/2008	PhD Uroš Urleb	1,132
4.	Z1-7586	Development of Mur Ligase Inhibitors as Novel Antibacterial Agents	9/1/2005 - 8/31/2007	PhD Uroš Urleb	410
5.	L1-6707	Design, synthesis and test of potencial hypolipidemic drugs with a new target	2/1/2004 - 1/30/2007	PhD Uroš Urleb	3,581
6.	L3-5084	Peptidominetiki - inhibitorji koagulacije krvi in agregacije trombocitov (Slovene)	1/1/2003 - 12/31/2005	PhD Mojca Stegnar	5,775
7.	L1-3261	Development of biologicaly active peptidomimetics	7/1/2001 - 12/31/2003	PhD Uroš Urleb	2,113
8.	L1-0469	Optimization of MDP and TNF analogues having therapeutic potential	7/1/1998 - 6/30/2000	PhD Anton Štalc	6,513
9.	J1-8889	Mimetics of biologically active peptides: Strategies of design and synthesis	1/1/1997 - 12/31/1999	PhD Danijel Kikelj	3,964
10.	L1-7379	Raziskave možnih implementacij dezmuramilnih analogov MDP in rekombinatnih analogov TNF-a v terapiji (Slovene)	1/1/1996 - 6/30/1998	PhD Anton Štalc	6,226
11.	J1-7053	Selektivni ligandi: sinteza, interakcije z makromolekulami in transport v biosistemih (Slovene)	1/1/1995 - 6/30/1998	PhD Aleš Mrhar	7,187

ARIS research and infrastructure programmes Legend

no.	Code	Title	Period	Head	No. of publications
1.	P1-0340	Design and preclinical development of novel drugs	1/1/2014 - 12/31/2017	PhD Uroš Urleb	1,554
2.	P1-0340	Načrtovanje in predklinični razvoj novih zdravilnih učinkovin (Slovene)	1/1/2009 - 12/31/2013	PhD Uroš Urleb	932
3.	P1-0340	Načrtovanje in predklinični razvoj novih zdravilnih učinkovin (Slovene)	7/1/2006 - 12/31/2008	PhD Uroš Urleb	1,608
4.	P1-0208	Medicinal chemistry - drug design, synthesis and evaluation	1/1/2004 - 12/31/2008	PhD Danijel Kikelj	6,446

We were not given permission by the researcher to publish data.